How CBD and THC are changing COVID-19 treatment


Given the coronavirus variants prevalent around the world, could THC and CBD offer benefits that are not yet known to treat and contain the deadly effects of the virus? While THC and CBD are already known to help with many diseases, scientists around the world are looking for different combinations and strains to better understand how they can reduce long-term complications and deaths.

For much of 2020 and as early as 2021, new studies are emerging based on previous evidence that establish a strong link between CBD and THC as agents against the virus. In fact, CBD is already making a difference with COVID-19.

Here are three important facts:

CBD has already been shown to reduce inflammation in the body, which is directly related to the damage from cytokines released by the coronavirus. Many COVID-19 patients did not die from the virus itself. The body’s response to the virus – a process known as a cytokine storm – caused the body to go into a “fight mode,” having difficulty breathing and over-saturation of cytokines caused in the body. Whenever a virus enters the body, it releases cytokines, a secretion from the cells that respond to the virus. This allows the immune system to return the favor. CBD could be an effective treatment for cytokine storms, which is causing the greatest havoc in the body. According to the medical journal, HealthEurope, “Initial results of a study currently being conducted by terpene maker Eybna and Israeli cannabis research and development company CannaSoul Analytics seem to suggest that the combination of terpenes and cannabinoids is up to two times more effective than the corticosteroid dexamethasone by reducing inflammation COVID-19. The study has not yet been peer-reviewed. ” Research continues overseas to determine the full effects of the virus and the possibilities of CBD for mitigating long-term harm. Research from Rabin Medical Center in Beilinson, a Leading Hospital from Clalit HMO, holds a reference to further studies. In recent research, the center’s team found that 8 out of 11 patients in the program saw an improvement in infections caused by the virus.

In January 2021, a clinical trial in Israel with Stero Biotechs was announced to “benefit and help COVID-19 patients in severe states with respiratory failure due to acute respiratory distress syndrome (ARDS)”. With heart damage being a major contributor to complications from COVID-19, many are looking for ways to lessen the effects of the virus on the body after infection. David Bassa, CEO of Stero Biotechs, has been a leader in the use of CBD and synthetic CBD in other studies, including Crohn’s disease and hives.

Photo by Mufid Majnun via Unsplash

THC and the fight against COVID-19

THC is also no stranger to the fight against the coronavirus. The University of South Carolina released a June 2020 study published in the Journal Limits in pharmacology, THC was effective in treating COVID complications and reducing mortality. The preliminary study found that with mice “THC resulted in 100% survival of the mice. “Using the compound that reduces anti-inflammatory cytokines, IFN-γ and TNF-α, eliminates the ‘cytokine storm’ or overreaction to the virus and finds out how certain cells and bacteria in the lungs play a vital role in understanding the range and extent of the extinction of COVID-19.

RELATED: Why Is Cannabis Not Prescribed For COVID Survivors?

Another study published by the journal nature In January 2021, the C. sativa strain of marijuana was found to have decreased inflammation against the virus and immune response markers. The study showed promising results, but emphasized caution with cannabis.

One thing is certain: the scientific community appears to be more embracing cannabis for the treatment of newer diseases, leading to better education and understanding for all.


Beth Edmonds